Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue
- PMID: 19623542
- PMCID: PMC3166332
- DOI: 10.1002/pros.21012
Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue
Abstract
Background: Low serum selenium concentration has been associated with increased risk of prostate cancer. A possible mechanism is through the antioxidant activity of selenoenzymes. However, the effect of selenium intake on selenoenzymes at target tissues is not well established. Hence, we investigated the correlation between serum and prostate tissue selenium concentrations and prostate tissue activity of glutathione peroxidase (GPX), a major selenoenzyme with antioxidant properties.
Methods: In an ongoing study investigating gene expression in prostate tissue, we measured serum selenium concentration in 98 men using atomic absorption spectrometry. Of these men, we selected 12 men with the highest and 12 men with the lowest serum selenium concentrations and measured selenium concentration and GPX activity in fresh frozen prostate tissue using the cyclic neutron activation analysis and a direct spectrophotometric procedure, respectively.
Results: The mean serum selenium concentrations among low and high selenium groups were 123.7 +/- 5.9 and 196.7 +/- 16.6 microg/L (P < 0.0001), respectively. The corresponding mean prostate tissue selenium concentrations were 1.39 +/- 0.28 and 1.65 +/- 0.42 microg/g (P = 0.08), resulting in a positive correlation between serum and prostate tissue selenium concentrations (r = 0.56, P = 0.02). The mean prostate tissue GPX activity was non-significantly greater in the low serum selenium group (32.2 +/- 8.4 U/g protein) than in the high serum selenium group (29.6 +/- 5.9 U/g protein) (P = 0.39) and it was not correlated with serum or prostate tissue selenium concentrations (r = -0.22, P = -0.37 for serum and r = -0.33, P = 0.18 for prostate tissue).
Conclusion: Serum and prostate tissue selenium concentrations were moderately correlated. In this population with relatively high selenium concentration, neither prostate tissue nor serum selenium concentrations were associated with prostate tissue GPX activity.
Figures
Similar articles
-
Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.Prostate. 2012 Jun 15;72(9):1006-12. doi: 10.1002/pros.21506. Epub 2011 Nov 9. Prostate. 2012. PMID: 22072582 Free PMC article.
-
Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk.J Nutr. 2006 Aug;136(8):2232-5. doi: 10.1093/jn/136.8.2232. J Nutr. 2006. PMID: 16857846 Clinical Trial.
-
Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia.Neoplasma. 2005;52(3):248-54. Neoplasma. 2005. PMID: 15875088
-
Serum selenium and risk of prostate cancer in U.S. blacks and whites.Int J Cancer. 2003 Feb 20;103(5):664-70. doi: 10.1002/ijc.10866. Int J Cancer. 2003. PMID: 12494476 Review.
-
Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.Free Radic Biol Med. 2018 Nov 1;127:36-45. doi: 10.1016/j.freeradbiomed.2017.12.039. Epub 2018 Jan 2. Free Radic Biol Med. 2018. PMID: 29305107 Review.
Cited by
-
Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1822-30. doi: 10.1158/1055-9965.EPI-11-0364. Epub 2011 Jul 15. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21765007 Free PMC article.
-
Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.Prostate. 2012 Jun 15;72(9):1006-12. doi: 10.1002/pros.21506. Epub 2011 Nov 9. Prostate. 2012. PMID: 22072582 Free PMC article.
-
[Prostate cancer prophylaxis by dietary supplements: more than just an illusion?].Urologe A. 2014 Nov;53(11):1610-9. doi: 10.1007/s00120-014-3614-1. Urologe A. 2014. PMID: 25312753 Review. German.
-
Selenium Supplementation and Prostate Health in a New Zealand Cohort.Nutrients. 2019 Dec 18;12(1):2. doi: 10.3390/nu12010002. Nutrients. 2019. PMID: 31861307 Free PMC article. Clinical Trial.
-
Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.Front Oncol. 2013 Sep 23;3:239. doi: 10.3389/fonc.2013.00239. eCollection 2013. Front Oncol. 2013. PMID: 24066278 Free PMC article.
References
-
- Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, Ma J. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst. 2004;96:696–703. - PubMed
-
- Van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2003;12:866–871. - PubMed
-
- Nomura AM, Lee J, Stemmermann GN, Combs GF., Jr Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:883–887. - PubMed
-
- Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92:2018–2023. - PubMed
-
- Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, Giovannucci E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90:1219–1224. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical